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ABSTRACT 36 
Objectives: To project risks of developing cancer and the number of cases potentially induced by 37 
past, current and future computed tomography (CT) scans performed in the UK in individuals 38 
under 20 years of age. 39 
Methods: Organ doses were estimated from surveys of individual scan parameters and CT 40 
protocols used in the UK. Frequencies of scans were estimated from the NHS Diagnostic 41 
Imaging Dataset. Excess lifetime risks (ELRs) of radiation-related cancer were calculated as 42 
cumulative lifetime risks, accounting for survival probabilities, using the RadRAT risk 43 
assessment tool.  44 
Results: In 2000-2008, ELRs ranged from 0.3 to 1 per 1,000 head scans, and 1 to 5 per 1,000 45 
non-head scans. ELRs per scan were reduced by 50-70% in 2000-2008 compared to 1990-1995, 46 
subsequent to dose reduction over time. The 130,750 scans performed in 2015 in the UK were 47 
projected to induce 64 (90% uncertainty interval (UI): 38-113) future cancers.  Current practices 48 
would lead to about 300 (90%UI: 230 to 680) future cancers induced by scans performed in 49 
2016-2020. 50 
Conclusion: Absolute excess risks from single exposures would be low compared to background 51 
risks, but even small increases in annual CT rates over the next years would substantially 52 
increase the number of potential subsequent cancers. 53 
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INTRODUCTION  54 
Fifteen years ago, Brenner and colleagues first assessed the possible magnitude of cancer risks 55 
induced by paediatric Computed Tomography (CT), and raised concerns about potential harmful 56 
effects of these x-ray exposures (Brenner et al., 2001). That study predicted risks of fatal cancer 57 
ranging from one per 10,000 to one per 1,000 scanned patients, depending on their age and the 58 
scanned body part. Based on current radiological practices at that time in the US, they projected 59 
that about 500 children scanned each year would ultimately die from a radiation-related cancer. 60 
Several investigators also reported the use of adult-calibrated scan parameters in paediatrics in 61 
this past period, resulting in unnecessarily high radiation doses in small body size patients 62 
(Mettler et al., 2000, Donnelly et al., 2001, Huda and Vance, 2007). 63 
Since then, direct evidence of increased cancer risks after CT scans received in childhood or 64 
early adulthood has been provided in epidemiological studies (Pearce et al., 2012, Mathews et 65 
al., 2013, Huang et al., 2014), although there were uncertainties in the dose estimates and a 66 
possibility of bias due to underlying medical conditions (Walsh et al., 2014, Berrington de 67 
Gonzalez et al., 2016). These studies have enhanced awareness about potential risks of x-ray 68 
exposures among the medical community and, along with considerable technological progress in 69 
CT, has led to further radiation dose optimisation in paediatrics. For instance, a survey in Great 70 
Britain showed that doses per scan were reduced by 50% in 2000-2008 compared to exposures 71 
before 1990 (Lee et al., 2016). At the same time, however, the number of examinations 72 
performed annually has considerably increased, in both adults and children (Pearce et al., 2011), 73 
due to the more widespread availability of CT scanners, the considerable reduction in scan times 74 
(which now makes the use of sedation unnecessary in most children), and improvements in CT 75 
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image quality allowing more medical applications. The increasing frequency of CT use has 76 
undoubtedly provided considerable medical benefits to children, but at the same time has 77 
increased the collective radiation exposure and the number of possible radiation-related cancers 78 
(Linton et al., 2003). In 2010, Parkin and Darby estimated that, in the UK, 0.6% of all cancers 79 
would be attributable to radiation exposures from diagnostic imaging in both pediatrics and 80 
adults (Parkin and Darby, 2011). 81 
Our aim here is to estimate the potential radiation-related cancer risks from current CT practice 82 
in the UK, specifically in paediatrics, compared to past practice, and to quantify the impact of the 83 
documented dose reductions. We then use data on frequency of CT use to project the numbers of 84 
future cancers possibly attributable to paediatric scans currently performed in the UK, or will be 85 
in the next five years, in individuals less than 20 years of age.  86 
METHODS  87 
Projection of Excess Lifetime Risks (ELRs) per scan 88 
To project future cancer risks, we used the RadRAT risk assessment tool, which was developed 89 
at the National Cancer Institute, Bethesda, MD, U.S. (Berrington de Gonzalez et al., 2012), and 90 
is now freely accessible at https://irep.nci.nih.gov/radrat. RadRAT incorporates an extended list 91 
of cancer site-specific risk models which were previously derived by the U.S. National Research 92 
Council in the BEIR VII report (NRC, 2006) from cohorts of survivors of the Hiroshima and 93 
Nagasaki atomic bombings and patients receiving radiotherapy for benign diseases or repeated 94 
diagnostic procedures. The above-mentioned recent studies on CT exposures cannot provide a 95 
full picture of radiation-related risks, mainly because their duration of follow-up is still too short 96 
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to describe cancer incidence after the age of 50 (Pearce et al., 2012, Mathews et al., 2013, Huang 97 
et al., 2014, Berrington de Gonzalez et al., 2016). In consequence, most of these studies 98 
estimated risks for a limited range of cancer sites. The risk estimates per unit dose were, 99 
however, compatible with the models implemented in RadRAT for leukemia and cerebral 100 
tumours (no estimate per unit dose is available for other cancer sites), once children with 101 
previous cancers or cancer-predisposing conditions were excluded (Berrington de Gonzalez et 102 
al., 2016). Current evidence from CT scans provides thus support for the appropriateness of the 103 
BEIR VII/RadRAT models for our risk projection purposes.  104 
From these models, ELRs of developing cancer were calculated for single CT scans, according to 105 
the patient’s age at exposure, gender, and scanned body part, as cumulative risks which would 106 
occur in addition to baseline cancer risks (i.e. without CT exposure) over a lifetime, while 107 
accounting for survival probabilities at each attained age. Survival functions (England, 2011-108 
2013) and baseline incidence rates (UK, 2011-2012) were collected from the Office for National 109 
Statistics (ONS) (www.ons.gov.uk, accessed on March 26, 2015). To account for risk projection 110 
uncertainties, 90% uncertainty intervals (UIs) were calculated as the 5th through to 95th 111 
percentile range of the distribution of ELR (or total number of future cancers) values computed 112 
by Monte Carlo simulations using RadRAT. As detailed in the methodological paper, probability 113 
distributions were assigned to each of the following components of risk projection: dose-114 
response model parameters, minimum latency period between radiation exposure and cancer 115 
occurrence, high-to-low doses risk extrapolation, and population-to-population risk transport, as 116 
well as to organ doses (see “Organ dose” section), to propagate uncertainties and dose variability 117 
in risk projection (Berrington de Gonzalez et al., 2012). All results on projected risks are 118 
displayed as median simulated values with 90% UI.  119 
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Projection of total number of future cancers in the UK  120 
The total number of cancers potentially related to annual frequencies of CT scans was calculated 121 
as a sum of estimated numbers of scans in a year for a given age groups, gender and scanned 122 
body part, multiplied by the corresponding ELRs. The presumed linear dose-response 123 
relationship for solid cancers and leukemia over the dose range of our interest (<0.5 Gy) (Preston 124 
et al., 2007, Wakeford, 2013), implies that the sum of projected risks for children who received 125 
multiple exposures is simply equal to the sum of projected risks per scan over all exposures in 126 
the population.  The number of cancers potentially related to future scans for the period 2016-127 
2020 was projected under different scenarios of dose reduction and future annual CT rates, 128 
which are detailed below. The total number of cancers potentially induced by past CT use (1990-129 
2012) was not projected, due to the lack of data on frequencies of paediatric CT scans in this 130 
time period, and the overly speculative nature of  retrospective risk projections over such a long 131 
period.  132 
Organ doses per scan 133 
Organ doses were estimated by age-at-exposure (0-4, 5-9, 10-14, 15-19 years), scanned body 134 
part (head, chest, abdomen-pelvis), gender and time period (1990-1994, 1995-1999, 2000-2008), 135 
mainly from individual scan parameters extracted from a sample of 1073 procedures in members 136 
of the UK CT cohort (Lee et al., 2016), to refine dosimetry since the first publication (Pearce et 137 
al., 2012). We converted the values of volume Computed Tomography Dose Index (CTDIvol) 138 
estimated  from the scan parameters into organ doses using conversion coefficients and standard 139 
landmarks, as described previously (Lee et al., 2016). For risk projection, the variability in organ 140 
doses was described by log-normal distributions derived from the 1,073 CT scan sample. For less 141 
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frequently scanned body parts (cervical spine, shoulders, hips) and particular protocols (high-142 
resolution, whole-body CT), data from the sample were very sparse. We thus used “typical”  143 
CTDIvol values published from two national surveys of CT protocols used in the UK (Kim et al., 144 
2012). For these infrequently scanned body parts, we did not account for dose variability (or 145 
uncertainty) in risk projection because no variability parameters were provided in the two 146 
national reference surveys. No dose estimation was performed for scans of the limbs because 147 
published values of CTDIvol were not reported separately for both legs and arms (Kim et al., 148 
2012), and conversion factors were not developed for arms (Lee et al., 2012). For risk projection 149 
in the period 2016-2020, we considered three scenarios of possible future dose reduction 150 
(constant, -20%, or -40%, as compared with doses per scan in 2000-2008), which would result 151 
from technological innovation and improved dose optimization (Raman et al., 2013, Dougeni et 152 
al., 2012).  153 
Frequencies of paediatric CT scans in the UK 154 
The total number of scans in England in 2013-2015 was collected from the Diagnostic Imaging 155 
Dataset (DID) which gathers information about all imaging tests carried out in England through 156 
the National Health Service (NHS) since April 2012 (reports accessible at www.england.nhs.uk). 157 
In the UK, paediatric CT scans are virtually all performed within the public NHS system. Data 158 
were obtained by 5-year age group and gender, excluding CT-guided procedures (e.g. biopsies or 159 
drainage) which are usually associated with very small doses. Procedures with unknown age or 160 
gender (<3%) were assumed to have the same age and gender distribution as scans with specified 161 
patients’ age and gender, and were added to sub-totals. To estimate the number of scans by body 162 
part, we applied frequencies by scan type and 5-year age groups estimated in the UK CT cohort 163 
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(Pearce et al., 2012). The number of scans throughout the UK was estimated by applying CT 164 
rates per 1,000 inhabitants in England by 5-year age group and calendar year to the 2012-based 165 
population projections for the whole of the UK published by the ONS (http://www.ons.gov.uk, 166 
accessed on March 7, 2016). The number of CT scans performed over the next five years was 167 
projected under various realistic scenarios of future changes in annual CT rates per inhabitant 168 
(constant, +5%, +3%, or -2%, as compared with the rates in 2015), and a “worst case” scenario 169 
of annual increase by 10% corresponding to CT trends observed in past years in other countries 170 
(Smith-Bindman et al., 2012, Brady et al., 2016, Dovales et al., 2016).  171 
RESULTS 172 
Excess Lifetime Risks associated with single CT scans, in 1990s and 2000s  173 
The projected ELR per scan decreased by 50-70% during the period 2000-2008 compared to the 174 
period 1990-1994, depending on age-at-exposure, gender and scanned body part (Figure 1). In 175 
2000-2008, ELRs ranged from 0.3 to 1 per 1,000 head scans, and 1 to 5 per 1,000 non-head 176 
scans (scans of the chest or abdomen and pelvis) according to patient gender and age (Table 1). 177 
For head scans, projected ELRs were similar for both genders, but, for non-head scans, ELRs 178 
were 1.5 to 3 times higher in girls than in boys due to higher risks of thyroid, breast, lung and 179 
gynecological cancers. As compared to a background lifetime risk of 40% in unexposed children, 180 
each single scan during childhood would lead to one excess case per 1,000 spontaneous cancers, 181 
on average. Uncertainties in risk projection were nevertheless large, e.g. for chest scans in girls 182 
aged 5 years, 90% of the simulated ELR values ranged from 1 to 13 per 1,000(Table 1). 183 
Number of future cancers potentially induced by scans performed in 2015 184 
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In England, the annual rate of CT use increased by 3% on average over the period 2013-2015, up 185 
to 8.5 scans per 1,000 in 2015. The 2015 rates were respectively 5.6, 3.8, 7.0, and 17.9 per 1,000 186 
in individuals aged 0 to 4, 5 to 9, 10 to 14, and 15 to 19 years. Based on these figures, we 187 
projected that 64 (90% UI: 38-113) future cancers would be induced by the 130,750 scans 188 
performed in 2015 in the UK in individuals aged <20 years. Girls accounted for 46% of the 189 
projected future cancers; adolescents aged 15-19 years accounted for half, and infants (<1-year-190 
old at scan) for almost 10% of projected future cancers (Figure 2). Cerebral tumours were the 191 
most frequent potentially radiation-related cancers, accounting for a fourth of all projected future 192 
cancers (Figure 3). Leukaemia, oral, lung, breast, and colorectal cancers accounted each for one 193 
out of ten. Despite the fact that cervical spine, chest, abdomen and/or pelvis scans accounted for 194 
only one-fifth of all examinations, tumours of organs located exclusively in the neck, thoracic or 195 
abdominal region (thyroid gland, breasts, lungs, digestive and urinary organs) accounted for half 196 
of all projected future cancers, due to their high sensitivity to radiation.  197 
Projected future cancers from different scenarios of CT practices up to 2020 198 
While considering the doses per scan during the period 2000-2008 and the CT rates of 2015 199 
remaining constant up to 2020, we calculated that 320 (90%UI: 230 to 680) future cancers would 200 
be induced by paediatric CT use in the UK over the next 5 years (Table 2). If the frequency of 201 
scans continues to increase by 3% per year up to 2020, this would lead to a number of potential 202 
future cancers increasing by 10%, as compared to constant CT rates. Rates increasing annually 203 
by 5% and 10% would be associated with increasing numbers of subsequent future cancers by 204 
16% and 34% respectively by 2020. Countering these projections are further CT dose reduction 205 
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techniques likely to be developed or implemented in the future, which would proportionally 206 
decrease the associated potential cancer risks (Table 2).  207 
DISCUSSION  208 
This study is an updated risk assessment for paediatric CT scans, which accounts for recent 209 
trends in radiation doses and frequency of use in the UK. Compared to the earliest period of CT 210 
use (before 1995), it shows that potential cancer risks per scan have been reduced by 50-70% in 211 
recent years due to dose reduction practices over time. With an estimated annual rate of 8.5 scans 212 
per 1,000 children and adolescents, resulting in a total of 131,000 scans in 2015, we projected 213 
that 40 to 110 children who were scanned in that year would ultimately develop a radiation-214 
related cancer over their lifetime. To put this in context, if we assume that 110,000 children were 215 
scanned that year (1.2 scan per child in average), 44,000 of these children would develop a 216 
cancer during their life, independently of their CT exposure in childhood (assuming a 217 
background lifetime risk of cancer of 40%).  218 
 An rough estimate of 5 future cancers per 10,000 paediatric scans from current practices in the 219 
UK is substantially lower than in previous studies conducted from past CT practices in the US, 220 
which estimated 8 cancer deaths (Brenner et al., 2001), and 10-12 incident cancers (Berrington 221 
de Gonzalez et al., 2009, Miglioretti et al., 2013) attributable to 10,000 paediatric scans. A 222 
reduction of risks per scan in the US by a similar extent to our estimates for the UK would be 223 
especially meaningful in terms of cancer burden reduction in this larger population. A projection 224 
rate of 5 future cancers per 10,000 scans would correspond to 3,400 future cancers possibly 225 
induced by the 6.8 million pediatric scans performed in the US in 2014 (IMV, 2014), as 226 
compared with the 7,000 to 8,000 future cancers that we project from the previous estimates 227 
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(Berrington de Gonzalez et al., 2009, Miglioretti et al., 2013). This reduction assumes that the 228 
reduced doses per scan observed in the UK also apply in the US, although, to our knowledge, no 229 
large-scale survey has described very recent trends in radiation doses in routine paediatric care in 230 
the US. Transposing current results for the UK to another population also assumes that the two 231 
populations have similar background risks, and distribution of age at scan and scanned body 232 
parts, which can be considered as a reasonable assumption (Ferlay et al., 2012).  233 
Other previous studies have projected cancer risks from paediatric CT scans. Most of them have 234 
reported radiation exposure and potential subsequent risks based on dedicated CT protocols, e.g. 235 
for monitoring of cystic fibrosis (de Jong et al., 2006), detection of renal calculi (Kuhns et al., 236 
2011), treatment of neurovascular diseases (Raelson et al., 2009), low-dose chest scan (Niemann 237 
et al., 2015), or coronary angiography (Huang et al., 2009). Few other studies have projected 238 
risks per scan from standard paediatric CT protocols, e.g. in the US (Li et al., 2011), France 239 
(Journy et al., 2014), and China (Su et al., 2014). None, to our knowledge, has previously 240 
considered routine practices in the UK. Many components differ between these studies, including 241 
population-specific background cancer risks and life expectancy, organ doses (scan parameters 242 
including length of scan region, and methods for organ dose estimation), risk models (though 243 
relatively homogeneous models were used in most studies), and methods to propagate risk 244 
projection uncertainties. However, a projection of 0.1 to 1 incident case (all cancer sites 245 
combined) per 1,000 head scans, and 1 to 5 per 1,000 non-head scans, is completely consistent 246 
among studies reporting all-cancer risks from standard CT protocols (Berrington de Gonzalez et 247 
al., 2009, Li et al., 2011, Miglioretti et al., 2013). With the use of largely similar risk models, 248 
these studies also consistently reported 2 to 7 times higher risks per scan in girls than boys (for 249 
non-head scans only), and 1.5 to 3 times higher risks per scan in neonates than adolescents aged 250 
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10-15 (for all scans) (Berrington de Gonzalez et al., 2009, Li et al., 2011, Miglioretti et al., 2013, 251 
Journy et al., 2014).  252 
The current study benefited from the use of empirical data on radiation doses and frequency of 253 
exposure in the UK for past and current time periods. The source of information used for organ 254 
dose estimation is the only one to include both individual variability and temporal trends from 255 
1990 to 2008 in the UK, and will be part of a refined dosimetry of the UK CT cohort (Lee et al., 256 
2016). Since the most recent period (2000-2008) of this survey, progress in CT technology and 257 
improved practices in dose optimization are likely to have reduced radiation doses that are 258 
currently delivered to patients, and to reduce them even more in the future. While future 259 
technological advances are unpredictable, we assessed different scenarios of dose reduction 260 
compatible with the expected gains from the widespread use of recent technological innovations 261 
(particularly automatic exposure control and iterative reconstruction) (Raman et al., 2013, 262 
Dougeni et al., 2012). A recent national survey in the UK, however, suggested few changes in 263 
CT practices in 2011 compared to 2003 (PHE, 2014). Future frequencies of CT use are also 264 
unpredictable, but “realistic” scenarios of future annual CT rates increasing by -2% to +5% 265 
would predict total numbers of possibly induced future cancers varying from -6% to +16% in the 266 
UK by the end of 2020, as compared with CT rates in 2015. A “worst case scenario” of annual 267 
rates increasing by 10% up to 2020 would lead to an increased total number of potential 268 
subsequent cancers by 34% in the next five years.  269 
As has been extensively discussed in the literature (NRC, 2006, UNSCEAR, 2012), the 270 
methodological framework for low-dose radiation risk projection has several limitations. In our 271 
particular context, the main sources of uncertainty are related to the shape of the dose-response 272 
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relationship, particularly at low doses (<0.1 Gy), the joint effect of radiation and other risk 273 
factors for cancer, the existence of modifying effects, such as age-at-exposure, and the latency 274 
time between radiation exposure and cancer diagnosis. Propagation of uncertainties through 275 
Monte Carlo simulations as implemented in RadRAT accounts for most of these sources of 276 
uncertainties to provide ranges of possible risk values. However, RadRat only considers one set 277 
of risk models and does not allow for different modelling of the dose-response relationship and 278 
modifying effects(Berrington de Gonzalez et al., 2012). Using the same reference data as used to 279 
estimate the BEIR VII/RadRAT models, other risk models have been preferred by other authors 280 
and scientific committees, in particular the United Nations Scientific Committee on the Effects 281 
of Atomic Radiation (UNSCEAR, 2006) and U.S. Environmental Protection Agency (EPA, 282 
2011). These models generally use different assumptions to model the dose-response relationship 283 
and account for confounding factors and effect modifiers. Attempts have been made to develop 284 
methods to account for model uncertainty based on goodness-of-fit criteria, but they might lead 285 
to omitting important confounding factors (Richardson and Cole, 2012) or effect modifiers (e.g. 286 
age-at-exposure), which could be critical for risk projection purposes.  287 
Extrapolation of risks from moderate-to-high doses (0.1 to >2 Gy) to the low dose range (<0.1 288 
Gy) of single CT exposures remains controversial (Doss, 2013). CT scan studies do not have a 289 
sufficient follow-up to provide risk estimates over a lifetime and for cancer sites which usually 290 
occur at old ages (e.g. thyroid, breast, lung, digestive cancers). These studies are nevertheless 291 
helpful to assess the validity of the BEIR VII/RadRAT models (or others) for risk projection 292 
purposes. First analyses in the UK and the Australian studies showed risk estimates for brain 293 
tumours that were higher than what the BEIR VII/RadRAT risk models would have predicted, 294 
with an Excess Relative Risk (ERR) per mGy of 0.02 (95%CI: 0.01 to 0.04) vs. 0.006 (95%CI: 0 295 
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to 0.06) in the a-bomb survivors who were exposed before age 20 and followed up to 20 years 296 
after exposure (Pearce et al., 2012, Mathews et al., 2013). However, a further analysis of the UK 297 
CT cohort showed that the risk estimates were reduced after excluding children with a previous 298 
unreported diagnosis of cancer or suspected tumour at the time of scan, with an ERR per mGy of 299 
0.01 (95%CI: 0.004-0.03) (Berrington de Gonzalez et al., 2016). After accounting for indication 300 
bias, this latest analysis thus provides risk estimates that are compatible with the results from the 301 
a-bomb survivor’ study, especially if we consider that a residual indication bias may remain in 302 
the CT risk estimates. The risk estimates for leukemia, including myelodysplasia, after CT 303 
exposures (ERRs per mGy comprised between 0.03 and 0.04 depending on the population 304 
considered) appeared also consistent with the results of the a-bomb survivor study (ERR per 305 
mGy=0.04) (Pearce et al., 2012, Mathews et al., 2013, Berrington de Gonzalez et al., 2016), 306 
which also includes cases of myelodysplasia during the early follow-up (Hsu et al., 2013). 307 
Current evidence from CT scan studies thus support the appropriateness of the BEIR 308 
VII/RadRAT models to evaluate potential risks subsequent to CT exposures at a population 309 
level. At the current time, this conclusion is however limited to brain tumors and leukemia only, 310 
as no dose-response analyses has been conducted to date for other cancer sites in studies with 311 
sufficient sample size. We thus acknowledge the need for further analyses with longer duration 312 
follow-up to fully address the issue of risk extrapolation to CT exposures.  313 
Finally, caution is required to avoid interpreting the current results as individual risks. As 314 
discussed below, large uncertainties exist when projecting risks from one particular situation of 315 
radiation exposure to another one, and we must acknowledge that the sensitivity to radiation 316 
varies according to individual factors, such as genetic susceptibility or other cancer risk factors 317 
(UNSCEAR, 2013) . In addition, we considered here that the current background cancer risks 318 
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and life expectancy of the general UK population applied in children who receive CT scans, 319 
without considering temporal changes and individual underlying medical conditions that may 320 
impact the risk of cancer and survival. A reduced survival probability will obviously reduce the 321 
risk of radiation-related effects over a lifetime (Brenner et al., 2011, Harbron et al., 2016). The 322 
current results should therefore only be interpreted at the population level to provide a sense of 323 
the magnitude of the potential risks and impact of collective exposures, and to assess possible 324 
future scenarios of CT practices. At the individual level, with potential absolute risks subsequent 325 
to CT exposures usually very low compared to the background lifetime risks of cancer, the 326 
immediate benefits of CT, as currently utilized in the UK, would largely outweigh the risks in 327 
most clinical situations. 328 
CONCLUSION 329 
Changes in practice have substantially reduced the radiation doses to children from CT scans in 330 
the UK, and potential subsequent cancer risks. However, the accompanying increase in 331 
frequency of scans has increased the collective exposure and the potential associated cancer 332 
burden. We estimated that about 230 to 680 future cancers would be induced by scans performed 333 
in children during 2016-2020 in the UK, if the frequency of CT use remains unchanged and no 334 
substantial further dose reduction occurs on a widespread scale. The absolute excess risk related 335 
to one CT scan would be very low as compared to background cancer risks that patients would 336 
face over their lifetime. Therefore, when paediatric CT is justified for a particular indication and 337 
other imaging tests are not adapted or available, the expected benefits of CT for children would 338 
largely outweigh the risks. However, because of the potential harmful effects of radiation 339 
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exposure, pediatric CT scans need to be used in accordance with clinical guidelines and with 340 
proper dose optimization to avoid unnecessary exposures and risks.  341 
 342 
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Year of scan 
Year of scan 
Year of scan 
23327 
15182 
24702 
67539 
(a) Number of CT scans  
in 2015 
All ages : 130,750 scans 
15 
8 
12 
30 
(b) Number of future cancers 
potentially induced  
All ages : 64 future cancers 
 0-4  5-9 10-14 15-19Age at scan (in years) 
NB: Figures are reported only for diagnostic scans; they exclude CT-guided procedures 
26% 
10% 
13% 
12% 
10% 
4% 
9% 
7% 
5% 
4% 
(b) Projected future cancers  
Brain & CNS
Leukemia
Lung
Oral Cavity & pharynx
Colon & rectum
Other digestive organs
Breast
Thyroid
Urinary organs
Others
71% 
2% 
7% 
9% 
3% 
8% 
(a) Body parts scanned by CT 
Head, facial bones
Cervical spine
Chest
Abdomen +/- pelvis
Pelvis
Extremities, hips, shoulders, whole body
CNS: central nervous system NB: Figures are reported only for diagnostic scans; they exclude CT-guided procedures. 
Frequencies of CT scans by scanned body part are reproduced from (Pearce et al., 2012). Projected numbers of potential future 
cancers are those which would occur over the entire individuals’ lifetime after CT exposures during childhood or adolescence 
Table 1: Projected Excess Lifetime Risk (ELR) and uncertainty intervals of all cancers incidence per 1,000 CT scans, according to the 
time period of scan, the scanned body part, patient’s gender and age  
Scanned 
body part  
Age (in 
years) Gender  
ELR (90% uncertainty interval) by time period Relative difference between time periods (%)* 
1990-1994  
(1) 
1995-1999  
(2) 
2000-2008  
(3) 
(2) vs 
(1) 
(3) vs 
(2) 
(3) vs 
(1) 
Head  0 Male  2.4 (1.2 to 4.8) 1.6 (0.6 to 4.1) 0.9 (0.4 to 2.3) -33 -44 -63 
Female  2.1 (1.0 to 4.0) 1.5 (0.7 to 3.2) 0.8 (0.4 to 2.0) -29 -47 -62 
5 Male  1.4 (0.7 to 2.7) 1.0 (0.4 to 2.7) 0.7 (0.3 to 1.7) -29 -30 -50 
Female  1.2 (0.6 to 2.0) 0.9 (0.4 to 1.8) 0.6 (0.3 to 1.3) -25 -33 -50 
15 Male  0.9 (0.4 to 1.8) 0.4 (0.2 to 1.3) 0.4 (0.2 to 1.2) -56  00 -56 
Female  0.6 (0.3 to 1.0) 0.3 (0.1 to 0.8) 0.3 (0.1 to 0.6) -50  00 -50 
Chest  0 Male  3.7 (1.8 to 8.7) 1.9 (0.8 to 5.0) 1.4 (0.5 to 6.0) -49 -26 -62 
Female  13.3 (6.5 to 24.8) 6.3 (2.7 to 16.3) 4.5 (1.5 to 16.5) -53 -29 -66 
5 Male  3.0 (1.4 to 7.1) 1.5 (0.7 to 4.1) 1.1 (0.4 to 4.9) -50 -27 -63 
Female  10.5 (5.0 to 18.3) 4.9 (2.1 to 12.6) 3.3 (1.1 to 12.8) -53 -33 -69 
15 Male  2.2 (1.2 to 4.3) 1.3 (0.6 to 3.2) 0.9 (0.4 to 2.1) -41 -31 -59 
Female  7.3 (4.2 to 11.4) 4.4 (1.9 to 8.8) 2.6 (1.3 to 6.4) -40 -41 -64 
Abdomen 
and pelvis  
0 Male  6.2 (3.0 to 12.4) 3.1 (1.4 to 7.7) 2.1 (0.8 to 7.1) -50 -32 -66 
Female  10.6 (5.5 to 20.0) 5.4 (2.7 to 11.7) 3.8 (1.5 to 10.9) -49 -30 -64 
5 Male  5.2 (2.5 to 10.1) 2.6 (1.2 to 6.3) 1.8 (0.7 to 5.8) -50 -31 -65 
Female  8.5 (4.4 to 16.1) 4.3 (2.2 to 9.4) 3.1 (1.2 to 8.6) -49 -28 -64 
15 Male  3.8 (2.1 to 7.4) 2.4 (1.2 to 5.3) 1.5 (0.7 to 3.6) -37 -38 -61 
Female  5.3 (3.2 to 9.9) 3.5 (1.6 to 7.0) 2.2 (1.1 to 4.5) -34 -37 -58 
ELR: median simulated value of Excess Lifetime Risk per 1,000 scans *Relative differences of median ELR values between two time periods 
  
 
Table 2: Projected number of future cancers potentially induced by CT scans performed over the next 5 years (period 2016-2020) in 
the UK, according to various scenarios of future practices in pediatrics 
Change in doses 
per scan as 
compared to 
practices  
in 2000-2008 
Change in 
annual CT rate 
per inhabitant 
as compared  
to 2015 
Projected future cancers 
potentially induced by scans 
performed in 2016-2020 (90% 
uncertainty interval) 
Avoided or additional future cancers 
as compared to the  
reference scenario 
absolute 
difference 
relative 
difference 
Dose remaining 
constant  
  
+10% 430 (300 to 870) +111 +34% 
+5% 370 (260 to 770) +52 +16% 
+3% 350 (250 to 730) +30 +9% 
+0% 320 (230 to 680) Reference scenario 
-2% 300 (220 to 650) -19 -6% 
20% reduction +10% 350 (240 to 700) 24 +7% 
+3% 280 (200 to 590) -40 -12% 
+0% 260 (180 to 540) -64 -20% 
40% reduction +10% 260 (180 to 520) -62 -19% 
+3% 210 (150 to 440) -111 -34% 
+0% 190 (140 to 410) -129 -40% 
The number of projected future cancers are rounded to the nearest 10. 
 
